Market Research Logo

Israel Pharmaceuticals and Healthcare Report Q2 2015

134 Pages BMI Research February 11, 2015 SKU: BMI5466949

Israel Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Israel offers an attractive pharmaceutical market, with the government committed to developingthe public healthcare system. An improving intellectual property regime and high penetration of patentedmedicines will be seen as positive by innovative drugmakers. Risks to our outlook include politicaluncertainty and the fiscal deficit, which pose a risk to the government's planned healthcare expenditure.

Headline Expenditure Projections

Pharmaceuticals: ILS7.51bn (USD2.10bn) in 2014 to ILS7.82bn (USD2.06bn) in 2015; +4.16% in localcurrency terms and -1.9% in US dollar terms.

Healthcare: ILS78.62bn (USD21.98bn) in 2014 to ILS83.62bn (USD22.01bn) in 2015; +6.4% in localcurrency terms and +0.1% in US dollar terms.

Show Full Description


Show Table of Contents



Israel Pharmaceuticals and Healthcare Report Q2 2015

BMI Research
February 11, 2015

Pricing & Delivery

Report with 3 quarterly updates
$1,295
Report with 3 quarterly updates - 3 User License
$1,945
Report with 3 quarterly updates - 5 User License
$2,500
Report with 3 quarterly updates - Departmental/Site License
$2,995
Global Site License Fulfilled by Publisher
$6,995

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.



CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.


Download CTA

Share this report